For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>

OUR INSPIRATION

Mr. I A Modi is the Founder Chairman of Cadila Pharmaceuticals Ltd.

Born in a small village of Hansot of Bharuch district in South Gujarat on February 18, 1926, Mr. Modi has left a long lasting impact on Indian Pharmaceuticals industry.

In newly independent India, when the myth was prevalent that Indian companies cannot make medicines Mr. Modi dared to foray into the pharmaceuticals industry and established Cadila and initiated a new era of pharmaceutical industry in the country. His entrepreneurship inspired many new young technocrats to venture into Pharma industry, which ultimately led India to self reliance in the pharmaceuticals Industry.

Mr. Modi is revered in the Indian Pharmaceutical Industry as the Champion of Indian Patents Act, 1970 which helped the Indian Pharmaceuticals Industry in attaining its present global status. He played a major role in giving shape to the 1986 Drug Policy of Government of India.

His contributions are widely acclaimed in the industry circles. Mr. Modi represented the National Working Group on Patent Laws, India (NWGPL) and Indian Drug Manufacturers’ Association (IDMA) on the subject “Patent Regime” proposed in the Uruguay Round at Delhi 1993.

He effectively championed the cause of national sector of the pharma industry and became a rallying point against the new patent regime during its consideration stages.

Under his leadership Cadila Pharmaceuticals achieved new milestones and offered many innovative and ‘firsts in the world’ medicines to the mankind including Rabeprazole in IV form for upper GI bleeding, Polycap for prevention of cardiovascular diseases, Risorine with booted Rifampicin for the treatment of Tuberculosis etc. He also has the credit to bring cutting edge technology VPL Virus Like particles) for vaccine manufacturing in India. Following in his vision, Cadila Pharmaceuticals continues to innovate and bring affordable medicines for the end users.

Mr. Modi has been a champion of Corporate Social Responsibility long before the concept became popular. In 1985, he established Kaka-Ba hospital with ultramodern facilities at a remote village to serve the needy poor patients.

He has been felicitated by many prestigious awards for his outstanding contribution to Pharma Industry.  To salute his vision of innovation,  CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu has launched Shri IA Modi Memorial Lecture Series and Cadila Pharmaceuticals has instituted the Indravadan Ambalal Modi Innovation Conclave (IAMICON) to celebrate innovations in Indian science – www.iamicon.in

 

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2017 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals